Product
Botulinum Toxin Type A Injection
Aliases
Botox®, Botulinum Toxin Type A Injection [Botox]
2 clinical trials
6 indications
Indication
Frown LinesIndication
DysphagiaIndication
Oropharyngeal DysphagiaIndication
Cricopharyngeus Muscle DysfunctionIndication
Difficulty swallowingIndication
Late Effects of StrokeClinical trial
A Double-blind, Randomized, Parallel, Active-controlled, Non-inferiority, Phase III Clinical Trial to Compare the Efficacy and Safety of HG102 Versus Botox® in Subjects With Moderate to Severe Glabellar LinesStatus: Recruiting, Estimated PCD: 2025-03-01
Clinical trial
Efficacy and Safety of Onabotulinum Toxin A (Botox) Injections in the Upper Esophageal Sphincter for the Treatment of Pharyngo-esophageal Dysphagia Due to Cricopharyngeal Dysfunction- A Randomized Double Blinded Placebo Controlled TrialStatus: Recruiting, Estimated PCD: 2023-12-31